(Q36784455)

16 August 2017

0 references

1 reference

title

Treatment of the mild cognitive impairment (MCI). (English)

1 reference

mild cognitive impairment

16 August 2017

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

Hervé Allain

1

1 reference

16 August 2017

Danièle Bentué-Ferrer

series ordinal

2

1 reference

16 August 2017

Yvette Akwa

series ordinal

3

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

published in

Human Psychopharmacology

1 reference

16 August 2017

volume

22

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

189-197

1 reference

Impaired cognition and attention in adults: pharmacological management strategies

16 August 2017

cites work

1 reference

The Women's Health Initiative Memory Study: findings and implications for treatment

21 January 2018

1 reference

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

21 January 2018

1 reference

Neuroprotection and neurodegenerative diseases: from biology to clinical practice

21 January 2018

1 reference

7 January 2021

Mild cognitive impairment: a treatment at last?

1 reference

7 January 2021

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

1 reference

7 January 2021

The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients

1 reference

7 January 2021

Revised criteria for mild cognitive impairment: validation within a longitudinal population study.

1 reference

7 January 2021

Blockade of 5-HT(3) receptor with MDL 72222 and Y 25130 reduces beta-amyloid protein (25--35)-induced neurotoxicity in cultured rat cortical neurons

1 reference

7 January 2021

Vitamin E treatment affects the progression of mild cognitive impairment to dementia

1 reference

7 January 2021

1 reference

7 January 2021

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

1 reference

7 January 2021

Mild cognitive impairment

1 reference

7 January 2021

Preclinical Alzheimer's disease: diagnosis and prediction of progression

1 reference

7 January 2021

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

1 reference

7 January 2021

Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment

1 reference

7 January 2021

gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo.

1 reference

7 January 2021

Mild Cognitive Impairment

1 reference

7 January 2021

Mild cognitive impairment in Parkinson's disease: the challenge and the promise

1 reference

7 January 2021

A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?

1 reference

7 January 2021

Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation

1 reference

7 January 2021

Mild cognitive impairment is not a clinical entity and should not be treated

1 reference

7 January 2021

Mild cognitive impairment

1 reference

7 January 2021

Indicators of neuroprotection with galantamine

1 reference

7 January 2021

Alzheimer's disease: translating neurochemical insights into clinical benefits

1 reference

7 January 2021

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

1 reference

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

7 January 2021

The impact of drugs against dementia on cognition in aging and mild cognitive impairment

1 reference

7 January 2021

Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report

1 reference

7 January 2021

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.

1 reference

7 January 2021

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

7 January 2021

Aging-Associated Cognitive Decline

1 reference

7 January 2021

Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?

1 reference

7 January 2021

Memory enhancement: the search for mechanism-based drugs

1 reference

7 January 2021

Protein twists and turns in Alzheimer disease

1 reference

7 January 2021

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

1 reference

7 January 2021

Antioxidants for the treatment of mild cognitive impairment.

1 reference

7 January 2021

Cognitive memory: cellular and network machineries and their top-down control

1 reference

7 January 2021

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

1 reference

7 January 2021

Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease

1 reference

7 January 2021

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

7 January 2021

Vitamin E and cognitive decline in older persons

1 reference

7 January 2021

Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment

1 reference

7 January 2021

Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment

1 reference

7 January 2021

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

1 reference

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

7 January 2021

Current concepts in mild cognitive impairment

1 reference

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

7 January 2021

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

1 reference

7 January 2021

A key role for the microglial NADPH oxidase in APP-dependent killing of neurons

1 reference

7 January 2021

Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.

1 reference

7 January 2021

Cholinergic treatment: what are the early neuropathological targets?

1 reference

7 January 2021

Tau suppression in a neurodegenerative mouse model improves memory function

1 reference

7 January 2021

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

7 January 2021

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

1 reference

7 January 2021

Mild cognitive impairment: emerging therapeutics

1 reference

7 January 2021

Role of androgens in mild cognitive impairment and possible interventions during andropause.

1 reference

7 January 2021

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

7 January 2021

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

1 reference

7 January 2021

Neuroprotective properties of memantine in differentin vitroandin vivomodels of excitotoxicity

1 reference

7 January 2021

Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism

1 reference

7 January 2021

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

1 reference

7 January 2021

Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease

1 reference

7 January 2021

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.838

1 reference

16 August 2017

1 reference